{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:11:47Z","timestamp":1790878307843,"version":"4.1.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Frailty is common in advanced chronic liver disease (AdvCLD). Key assessment tools for frailty in this population include the liver frailty index (LFI), the 6-minute walk test (6MWT), and the gait speed test (GST). This study investigates the relationship between free testosterone (FT) levels and these frailty measures in men with AdvCLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In this prospective cohort study of 197 male AdvCLD patients awaiting liver transplantation, frailty was assessed using the LFI, 6MWT, and GST. Participants were classified as having low or normal FT levels, and associations with frailty measures were analyzed using multivariable linear and logistic regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of the 197 patients, 41 (20.8%) had low FT levels. This group was more likely to have a higher Child-Turcotte-Pugh class, higher MELD-Na scores, and a history of hepatic encephalopathy compared with patients with normal FT levels (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.05). Those with low FT also demonstrated greater frailty, with significantly poorer performance on the LFI and shorter distances on the 6MWT (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.05); the GST difference did not reach statistical significance (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.106). In multivariable regression analysis, including age, MELD-Na score, and Child-Turcotte-Pugh score, only low FT levels (OR: 2.4,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.043) were independently associated with frailty. Similarly, in multivariable linear regression, FT levels were independently associated with LFI scores and 6MWT (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Low FT is associated with increased frailty in male patients with AdvCLD. Additional research may help identify therapeutic approaches to improve frailty in this patient group.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mcg.0000000000002192","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T18:00:15Z","timestamp":1754330415000},"page":"661-666","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["The Association of Free Testosterone Levels With Frailty Metrics in Advanced Chronic Liver Disease"],"prefix":"10.1097","volume":"60","author":[{"given":"Miguel","family":"Sogbe","sequence":"first","affiliation":[{"name":"Liver Unit, Clinica Universidad de Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Bromfield","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Tellez","sequence":"additional","affiliation":[{"name":"Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela M.","family":"Bloomer","sequence":"additional","affiliation":[{"name":"Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Herrera-Caceres","sequence":"additional","affiliation":[{"name":"Department of Urology, Penn State Health, Hershey, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Dunn","sequence":"additional","affiliation":[{"name":"Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5377-9295","authenticated-orcid":false,"given":"Andres","family":"Duarte-Rojo","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Northwestern University, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8]]},"reference":[{"key":"R1-20260625","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1053\/j.gastro.2019.01.028","article-title":"Frailty associated with waitlist mortality independent of ascites and hepatic encephalopathy in a multicenter study","volume":"156","author":"Lai","year":"2019","journal-title":"Gastroenterology"},{"key":"R2-20260625","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/lt.26052","article-title":"Physiologic reserve assessment and application in clinical and research settings in liver transplantation","volume":"27","author":"Bhanji","year":"2021","journal-title":"Liver Transpl"},{"key":"R3-20260625","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/lt.24958","article-title":"Exercise and physical activity for patients with end-stage liver disease: improving functional status and sarcopenia while on the transplant waiting list","volume":"24","author":"Duarte-Rojo","year":"2018","journal-title":"Liver Transpl"},{"key":"R4-20260625","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/j.jhep.2021.01.025","article-title":"Sarcopenia and frailty in decompensated cirrhosis","volume":"75","author":"Tandon","year":"2021","journal-title":"J Hepatol"},{"key":"R5-20260625","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/CIA.S189040","article-title":"Relationship between nutritional status and frailty in hospitalized older patients","volume":"14","author":"Hong","year":"2019","journal-title":"Clin Interv Aging"},{"key":"R6-20260625","doi-asserted-by":"crossref","first-page":"e15412","DOI":"10.1111\/ctr.15412","article-title":"Comparing functional frailty and radiographic sarcopenia as predictors of outcomes after liver transplant","volume":"38","author":"Olson","year":"2024","journal-title":"Clin Transplant"},{"key":"R7-20260625","doi-asserted-by":"crossref","first-page":"615","DOI":"10.5604\/01.3001.0012.0930","article-title":"Association between Low testosterone levels and sarcopenia in cirrhosis: a cross-sectional study","volume":"17","author":"Moctezuma-Vel\u00e1zquez","year":"2018","journal-title":"Ann Hepatol"},{"key":"R8-20260625","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1530-0277.1990.tb00507.x","article-title":"Effect of liver transplantation on the hypothalamic-pituitary-gonadal axis of chronic alcoholic men with advanced liver disease","volume":"14","author":"Van Thiel","year":"1990","journal-title":"Alcohol Clin Exp Res"},{"key":"R9-20260625","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.29219","article-title":"Development of a novel frailty index to predict mortality in patients with end-stage liver disease","volume":"66","author":"Lai","year":"2017","journal-title":"Hepatology"},{"key":"R10-20260625","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/lt.25449","article-title":"The range and reproducibility of the liver frailty index","volume":"25","author":"Wang","year":"2019","journal-title":"Liver Transplant"},{"key":"R11-20260625","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","author":"Crapo","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"R12-20260625","doi-asserted-by":"crossref","first-page":"100327","DOI":"10.1016\/j.aohep.2021.100327","article-title":"Frailty and reduced gait speed are independently related to mortality of cirrhotic patients in long-term follow-up","volume":"25","author":"Soto","year":"2021","journal-title":"Ann Hepatol"},{"key":"R13-20260625","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/jgh.12695","article-title":"Testosterone in men with advanced liver disease: abnormalities and implications","volume":"30","author":"Sinclair","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"R14-20260625","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2265.1995.tb02040.x","article-title":"Hypothalamic-pituitary-testicular function in end-stage non-alcoholic liver disease before and after liver transplantation","volume":"43","author":"Handelsman","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R15-20260625","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"R16-20260625","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-20260625","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/hep4.1688","article-title":"Assessment of the frail patient with end-stage liver disease: a practical overview of sarcopenia, physical function, and disability","volume":"5","author":"Williams","year":"2021","journal-title":"Hepatol Commun"},{"key":"R18-20260625","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ajg.2017.443","article-title":"The liver frailty index improves mortality prediction of the subjective clinician assessment in patients with cirrhosis","volume":"113","author":"Lai","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"R19-20260625","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jceh.2021.11.012","article-title":"High prevalence of hormonal changes and hepatic osteodystrophy in frail patients with cirrhosis-an observational study","volume":"12","author":"Singh","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"R20-20260625","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/lt.26087","article-title":"The 6-minute walk test distance predicts mortality in cirrhosis: a cohort of 694 patients awaiting liver transplantation","volume":"27","author":"Dang","year":"2021","journal-title":"Liver Transpl"},{"key":"R21-20260625","doi-asserted-by":"crossref","first-page":"e14108","DOI":"10.1111\/eci.14108","article-title":"The association of testosterone with sarcopenia and frailty in chronic liver disease","volume":"54","author":"Chrysavgis","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"R22-20260625","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/liv.13122","article-title":"High circulating oestrone and low testosterone correlate with adverse clinical outcomes in men with advanced liver disease","volume":"36","author":"Sinclair","year":"2016","journal-title":"Liver Int"},{"key":"R23-20260625","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/hepr.13253","article-title":"Dysbalanced sex hormone status is an independent predictor of decompensation and mortality in patients with liver cirrhosis","volume":"49","author":"Paternostro","year":"2019","journal-title":"Hepatol Res"},{"key":"R24-20260625","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1249\/MSS.0b013e318237c5c0","article-title":"Androgens affect myogenesis in vitro and increase local IGF-1 expression","volume":"44","author":"Sculthorpe","year":"2012","journal-title":"Med Sci Sports Exerc"},{"key":"R25-20260625","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jhep.2016.07.040","article-title":"Sarcopenia from mechanism to diagnosis and treatment in liver disease","volume":"65","author":"Dasarathy","year":"2016","journal-title":"J Hepatol"},{"key":"R26-20260625","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3390\/jcm8050732","article-title":"Substance abuse and male hypogonadism","volume":"8","author":"Duca","year":"2019","journal-title":"J Clin Med"},{"key":"R27-20260625","doi-asserted-by":"crossref","first-page":"18162","DOI":"10.1073\/pnas.1317049110","article-title":"Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-\u03baB-mediated mechanism","volume":"110","author":"Qiu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R28-20260625","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jhep.2016.06.007","article-title":"Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: a randomised controlled trial","volume":"65","author":"Sinclair","year":"2016","journal-title":"J Hepatol"},{"key":"R29-20260625","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.clinre.2011.09.005","article-title":"Effects of testosterone gel treatment in hypogonadal men with liver cirrhosis","volume":"35","author":"Yurci","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R31-20260625","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/lt.25950","article-title":"Introducing EL-FIT (Exercise and Liver FITness): a smartphone app to prehabilitate and monitor liver transplant candidates","volume":"27","author":"Duarte-Rojo","year":"2021","journal-title":"Liver Transpl"},{"key":"R32-20260625","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.14309\/ajg.0000000000001376","article-title":"Prehabilitation-driven changes in frailty metrics predict mortality in patients with advanced liver disease.","volume":"116","author":"Lin","year":"2021","journal-title":"Am J Gastroenterol"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCG.0000000000002192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:01:04Z","timestamp":1782428464000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCG.0000000000002192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0000000000002192","relation":{},"ISSN":["1539-2031"],"issn-type":[{"value":"1539-2031","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"2025-01-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}